The Response of Drug Expenditures to Non-Linear Contract Design: Evidence from Medicare Part D
---- Acknowledgements -----
We thank Jason Abaluck, Raj Chetty, John Friedman, Nathan Hendren, Maria Polyakova, and many seminar participants for helpful discussions. Ray Kluender provided extraordinary research assistance. We gratefully acknowledge support from the NIA (R01 AG032449). The views expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic Research.
---- Disclosure of Financial Relationships for Liran Einav -----
This paper draws on some of my experience in related work that used proprietary data from various companies, which were obtained through contracts that I and my coauthors signed with each of these companies (eBay Research, Alcoa, Safeway, and a subprime lender).